Drug resistance in Malaria-in a nutshell
暂无分享,去创建一个
[1] S. Croft,et al. Synthesis and evaluation of cryptolepine analogues for their potential as new antimalarial agents. , 2001, Journal of medicinal chemistry.
[2] S. Hoffman,et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine , 1993, The Lancet.
[3] Sanjay Kumar,et al. Free heme toxicity and its detoxification systems in human. , 2005, Toxicology letters.
[4] H. Ginsburg,et al. Identification of the acidic compartment of Plasmodium falciparum‐infected human erythrocytes as the target of the antimalarial drug chloroquine. , 1984, The EMBO journal.
[5] Matthew E Falagas,et al. Insights into infectious disease in the era of Hippocrates. , 2008, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.
[6] B. Medhi,et al. Challenges of drug-resistant malaria , 2014, Parasite.
[7] C. MacPherson,et al. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system , 2014, Nature Biotechnology.
[8] M. Foley,et al. Quinoline antimalarials: mechanisms of action and resistance and prospects for new agents. , 1998, Pharmacology & therapeutics.
[9] J. Dame,et al. Survey of Plasmodium falciparum multidrug resistance-1 and chloroquine resistance transporter alleles in Haiti , 2013, Malaria Journal.
[10] Leann Tilley,et al. Identification and Characterization of Heme-interacting Proteins in the Malaria Parasite, Plasmodium falciparum* , 2003, Journal of Biological Chemistry.
[11] S. Meshnick,et al. Cytochrome b Mutations That Modify the Ubiquinol-binding Pocket of the Cytochrome bc1 Complex and Confer Anti-malarial Drug Resistance in Saccharomyces cerevisiae* , 2005, Journal of Biological Chemistry.
[12] D. Greenwood,et al. The quinine connection. , 1992, The Journal of antimicrobial chemotherapy.
[13] A. Cowman,et al. Chemotherapy and drug resistance in malaria. , 1990, International journal for parasitology.
[14] E. Hsu. Reflections on the 'discovery' of the antimalarial qinghao. , 2006, British journal of clinical pharmacology.
[15] S. Meshnick,et al. Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi. , 2007, Trends in parasitology.
[16] V. Choubey,et al. Antimalarial drugs inhibiting hemozoin (β-hematin) formation: A mechanistic update , 2007 .
[17] X. Su,et al. Disruption of a Plasmodium falciparum Multidrug Resistance-associated Protein (PfMRP) Alters Its Fitness and Transport of Antimalarial Drugs and Glutathione , 2009, Journal of Biological Chemistry.
[18] X. Su,et al. Dissecting the loci of low‐level quinine resistance in malaria parasites , 2004, Molecular microbiology.
[19] S. Ward,et al. Chloroquine resistance of Plasmodium falciparum: further evidence for a lack of association with mutations of the pfmdr1 gene. , 1994, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[20] B. Nilius,et al. Inhibition of volume-regulated and calcium-activated chloride channels by the antimalarial mefloquine. , 2000, The Journal of pharmacology and experimental therapeutics.
[21] Y. Wu,et al. How Chinese scientists discovered qinghaosu (artemisinin) and developed its derivatives? What are the future perspectives? , 1998, Medecine tropicale : revue du Corps de sante colonial.
[22] D. Fidock,et al. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates , 2015, Science.
[23] K. Saliba,et al. Role for the plasmodium falciparum digestive vacuole in chloroquine resistance. , 1998, Biochemical pharmacology.
[24] Dobson Mj. Malaria in England: a geographical and historical perspective. , 1994, Parassitologia.
[25] A F Slater,et al. Chloroquine: mechanism of drug action and resistance in Plasmodium falciparum. , 1993, Pharmacology & therapeutics.
[26] D. Fidock,et al. Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum , 2006, The EMBO journal.
[27] R. Gwilliam,et al. Sequence of Plasmodium falciparum chromosomes 1, 3–9 and 13 , 2002, Nature.
[28] Kyle Ra,et al. Discoverers of quinine. , 1974 .
[29] K. Kirk,et al. Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance , 2005, Molecular microbiology.
[30] R. Basir,et al. Role of Different Pfcrt and Pfmdr-1 Mutations in Conferring Resistance to Antimalaria Drugs in Plasmodium falciparum , 2014, Malaria research and treatment.
[31] Jonathan E. Allen,et al. Sequence of Plasmodium falciparum chromosomes 2, 10, 11 and 14 , 2002, Nature.
[32] H. Webster,et al. TYPE II MEFLOQUINE RESISTANCE IN THAILAND , 1982, The Lancet.
[33] K. Rieckmann,et al. Mefloquine (WR 142,490) in the treatment of human malaria , 1975, Science.
[34] M. Fukuda,et al. Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.
[35] L. Canier,et al. Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study , 2014, Malaria Journal.
[36] X. Su,et al. Artemisinin: Discovery from the Chinese Herbal Garden , 2011, Cell.
[37] Joanne M. Morrisey,et al. Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum , 2007, Nature.
[38] Margaret Humphreys,et al. Malaria and Rome : a history of malaria in ancient Italy , 2003 .
[39] D. Saunders,et al. Dihydroartemisinin-piperaquine failure in Cambodia. , 2014, The New England journal of medicine.
[40] H. Tinto,et al. Chloroquine‐resistance molecular markers (Pfcrt T76 and Pfmdr‐1 Y86) and amodiaquine resistance in Burkina Faso , 2008, Tropical medicine & international health : TM & IH.
[41] P. Stevens. Diseases of poverty and the 10/90 Gap , 2008 .
[42] J. Wootton,et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. , 2000, Molecular cell.
[43] H. W. Lee,et al. Border malaria characters of reemerging vivax malaria in the Republic of Korea. , 1999, The Korean journal of parasitology.
[44] R. Packard. Agricultural development, migrant labor and the resurgence of malaria in Swaziland. , 1986, Social science & medicine.
[45] S. Canali. Researches on thalassemia and malaria in Italy and the origins of the "Haldane hypothesis". , 2008, Medicina nei secoli.
[46] D. Fidock,et al. Differences in trans‐stimulated chloroquine efflux kinetics are linked to PfCRT in Plasmodium falciparum , 2007, Molecular microbiology.
[47] E. Hempelmann,et al. Bad air, amulets and mosquitoes: 2,000 years of changing perspectives on malaria , 2013, Malaria Journal.
[48] R. Ridley. Malaria: To kill a parasite , 2003, Nature.
[49] P. Roepe,et al. Plasmodium falciparum Na+/H+ exchanger activity and quinine resistance. , 2007, Molecular and biochemical parasitology.
[50] R. N. Brogden,et al. Mefloquine , 1993, Drugs.
[51] G. Poinar,et al. Plasmodium dominicana n. sp. (Plasmodiidae: Haemospororida) from Tertiary Dominican amber , 2005, Systematic Parasitology.
[52] B. Tekwani,et al. 8-Aminoquinolines: future role as antiprotozoal drugs , 2006, Current opinion in infectious diseases.
[53] C. Plowe,et al. Mechanisms of Resistance of Malaria Parasites to Antifolates , 2005, Pharmacological Reviews.
[54] ACTIVITY of a new antimalarial agent, chloroquine (SN 7618). , 1946, Journal of the American Medical Association.
[55] A. Cowman,et al. Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum. , 1993, Molecular and biochemical parasitology.
[56] J. Wootton,et al. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. , 2001, The Journal of infectious diseases.
[57] D Payne,et al. Spread of chloroquine resistance in Plasmodium falciparum. , 1987, Parasitology today.
[58] David A. Fidock,et al. Chloroquine Resistance in Plasmodium falciparum Malaria Parasites Conferred by pfcrt Mutations , 2002, Science.
[59] S. Krishna,et al. Artemisinins target the SERCA of Plasmodium falciparum , 2003, Nature.
[60] C. D. Fitch,et al. The antimalarial drug mefloquine binds to membrane phospholipids , 1982, Antimicrobial Agents and Chemotherapy.
[61] D. Warhurst,et al. Lysosomes, pH and the Anti-malarial Action of Chloroquine , 1972, Nature.
[62] M. Mather,et al. Mitochondrial evolution and functions in malaria parasites. , 2009, Annual review of microbiology.
[63] J. Mouchet,et al. [Malaria in Guiana. II. The characteristics of different foci and antimalarial control]. , 1989, Bulletin de la Societe de pathologie exotique et de ses filiales.
[64] F. Nosten,et al. Are Transporter Genes Other than the Chloroquine Resistance Locus (pfcrt) and Multidrug Resistance Gene (pfmdr) Associated with Antimalarial Drug Resistance? , 2005, Antimicrobial Agents and Chemotherapy.
[65] D. Kwiatkowski,et al. Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance , 2015, Science.
[66] B. Genton,et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria , 2013, Nature.
[67] S. Meshnick,et al. Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action. , 1991, Molecular and biochemical parasitology.
[68] S. Looareesuwan,et al. Primaquine-tolerant vivax malaria in Thailand. , 1997, Annals of tropical medicine and parasitology.
[69] R. Maude,et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker , 2015, The Lancet. Infectious diseases.
[70] Pedro Alonso,et al. Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials , 2009, The Lancet.
[71] S. Briolant,et al. Absence of Association between Piperaquine In Vitro Responses and Polymorphisms in the pfcrt, pfmdr1, pfmrp, and pfnhe Genes in Plasmodium falciparum , 2010, Antimicrobial Agents and Chemotherapy.
[72] S. Ward,et al. Physicochemical properties correlated with drug resistance and the reversal of drug resistance in Plasmodium falciparum. , 1996, Molecular pharmacology.
[73] K. Kirk,et al. Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum , 2000, Nature.
[74] P. Schlesinger,et al. Antimalarial agents: mechanisms of action , 1988, Antimicrobial Agents and Chemotherapy.